Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

Sanofi reception

Sanofi and Novartis snap up immuno-oncology candidates

Separate licensing deals see the firms look to catch up with the category's leaders

- PMLiVE

Mylan buys into six biosimilars, including Orencia candidate

Deal with Momenta bolsters biosimilars pipeline for new products

- PMLiVE

ViiV and Janssen plan pivotal trials of monthly HIV treatment

Rilpivirine – cabotegravir combination could provide a monthly option

Deal Watch December 2015

The month’s deals see a number of collaboration and licensing deals for technology platforms and new molecule discovery

- PMLiVE

Boehringer Ingelheim on walking the talk in patient-centricity

UK medical director Professor Klaus Dugi on patient engagement

- PMLiVE

Pharma sales in the digital era

A successful marketing strategy must embrace customer preferences and strive for a channel mix that provides the right information at the audience's convenience

- PMLiVE

Adapting to the digital consumer

The trends affecting all segments of the wider healthcare ecosystem

- PMLiVE

Pragmatic digital health

Pharma will have to move beyond tech hype if its digital efforts are to have a genuine impact

- PMLiVE

Former Roche development head joins Asana advisory board

Dr Kapil Dhingra also brings experience from Lilly

Srdjan Stankovic joins Acadia Pharmaceuticals

He moves to the San Diego biopharma from Alkermes

Roche Basel Switzerland

Roche prepares to file atezolizumab for bladder cancer

Imminent submission to the FDA after additional positive phase II trial results

Biogen Idec building

Biogen buys into Rodin’s Alzheimer’s candidate

And may acquire the epigenetics-focused Massachusetts firm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links